By combining two high-throughput technologies, combinatorial peptide library biopanning on serum IgG or IgM antibodies and microarray-based gene expression analysis, the peptides representing sequential epitopes of the subset of tumor-associated antigens for a cancer patient can be easily and quickly identified. This evidence concerns the gene CD40LG and neoplasm.